Authentic GITR signaling fails to induce tumor regression unless Foxp3+ regulatory T cells are depleted

Journal of Immunology

Volumn 195, Issue 10, 2015, Pages 4721-4729

  Kim, Young H ^a   Shin, Su M ^a   Choi, Beom K ^a   Oh, Ho S ^a   Kim, Chang H ^a   Lee, Seung J ^a   Kim, Kwang H ^a   Lee, Don G ^a   Park, Sang H ^a   Kwon, Byoung S ^a,b  

^a National Cancer Center   (South Korea)

^b TULANE UNIVERSITY HEALTH SCIENCES CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOCORTICOID INDUCED TUMOR NECROSIS FACTOR RECEPTOR; LIGAND; TRANSCRIPTION FACTOR FOXP3; FORKHEAD TRANSCRIPTION FACTOR; FOXP3 PROTEIN, MOUSE; MONOCLONAL ANTIBODY; PROTEIN BINDING; TNFRSF18 PROTEIN, MOUSE; TNFSF18 PROTEIN, MOUSE; TUMOR NECROSIS FACTOR;

ADAPTIVE IMMUNITY; ADENOCARCINOMA; ANIMAL EXPERIMENT; ARTICLE; CD4+ T LYMPHOCYTE; CELL PROLIFERATION; CONTROLLED STUDY; DENDRITIC CELL; EFFECTOR CELL; HUMORAL IMMUNITY; IN VITRO STUDY; IN VIVO STUDY; LYMPH NODE; MOUSE; NONHUMAN; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; T CELL DEPLETION; TUMOR REGRESSION; ANIMAL; C57BL MOUSE; GENETICS; HUMAN; IMMUNOLOGY; LYMPHOCYTE ACTIVATION; LYMPHOCYTE COUNT; LYMPHOCYTE DEPLETION; METABOLISM; NEOPLASM; SIGNAL TRANSDUCTION; TUMOR CELL LINE;

ANIMALS; ANTIBODIES, MONOCLONAL; CELL LINE, TUMOR; CELL PROLIFERATION; FORKHEAD TRANSCRIPTION FACTORS; GLUCOCORTICOID-INDUCED TNFR-RELATED PROTEIN; HUMANS; LYMPHOCYTE ACTIVATION; LYMPHOCYTE COUNT; LYMPHOCYTE DEPLETION; MICE; MICE, INBRED C57BL; NEOPLASMS; PROTEIN BINDING; SIGNAL TRANSDUCTION; T-LYMPHOCYTES, REGULATORY; TUMOR NECROSIS FACTORS;

EID: 84958625170     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1403076     Document Type: Article

References (34)

1. Shimizu, J., S. Yamazaki, T. Takahashi, Y. Ishida, and S. Sakaguchi. 2002. Stimulation of CD25(+)CD4(+) regulatory T cells through GITR breaks immunological self-tolerance. Nat. Immunol. 3: 135-142.
2. Ronchetti, S., O. Zollo, S. Bruscoli, M. Agostini, R. Bianchini, G. Nocentini, E. Ayroldi, and C. Riccardi. 2004. GITR, a member of the TNF receptor superfamily, is costimulatory to mouse T lymphocyte subpopulations. Eur. J. Immunol. 34: 613-622.
3. Shevach, E. M., and G. L. Stephens. 2006. The GITR-GITRL interaction: costimulation or contrasuppression of regulatory activity? Nat. Rev. Immunol. 6: 613-618.
4. Kim, J. D., B. K. Choi, J. S. Bae, U. H. Lee, I. S. Han, H. W. Lee, B. S. Youn, D. S. Vinay, and B. S. Kwon. 2003. Cloning and characterization of GITR ligand. Genes Immun. 4: 564-569.
5. Tone, M., Y. Tone, E. Adams, S. F. Yates, M. R. Frewin, S. P. Cobbold, and H. Waldmann. 2003. Mouse glucocorticoid-induced tumor necrosis factor receptor ligand is costimulatory for T cells. Proc. Natl. Acad. Sci. USA 100: 15059-15064.
6. Ko, K., S. Yamazaki, K. Nakamura, T. Nishioka, K. Hirota, T. Yamaguchi, J. Shimizu, T. Nomura, T. Chiba, and S. Sakaguchi. 2005. Treatment of advanced tumors with agonistic anti-GITR mAb and its effects on tumor-infiltrating Foxp3+CD25+CD4+ regulatory T cells. J. Exp. Med. 202: 885-891.
7. Zhou, P., L. L'italien, D. Hodges, and X. M. Schebye. 2007. Pivotal roles of CD4+ effector T cells in mediating agonistic anti-GITR mAb-inducedimmune activation and tumor immunity in CT26 tumors. J. Immunol. 179: 7365-7375.
8. La, S., E. Kim, and B. Kwon. 2005. In vivo ligation of glucocorticoid-induced TNF receptor enhances the T-cell immunity to herpes simplex virus type 1. Exp. Mol. Med. 37: 193-198.
9. Hoffmann, C., J. Stanke, A. M. Kaufmann, C. Loddenkemper, A. Schneider, and G. Cichon. 2010. Combining T-cell vaccination and application of agonistic anti-GITR mAb (DTA-1) induces complete eradication of HPV oncogene expressing tumors in mice. J. Immunother. 33: 136-145.
10. Kohm, A. P., J. S. Williams, and S. D. Miller. 2004. Cutting edge: ligation of the glucocorticoid-induced TNF receptor enhances autoreactive CD4+ T cell activation and experimental autoimmune encephalomyelitis. J. Immunol. 172: 4686-4690.
11. Uraushihara, K., T. Kanai, K. Ko, T. Totsuka, S. Makita, R. Iiyama, T. Nakamura, and M. Watanabe. 2003. Regulation of murine inflammatory bowel disease by CD25+ and CD25- CD4+ glucocorticoid-induced TNF receptor family-related gene+ regulatory T cells. J. Immunol. 171: 708-716.
12. Lee, S. K., B. K. Choi, Y. H. Kim, W. J. Kang, K. H. Kim, S. Sakaguchi, J. H. Suh, T. Y. Kim, and B. S. Kwon. 2006. Glucocorticoid-induced tumour necrosis factor receptor family-related receptor signalling exacerbates hapteninduced colitis by CD4+ T cells. Immunology 119: 479-487.
13. Ponte, J. F., P. Ponath, R. Gulati, M. Slavonic, M. Paglia, A. O'Shea, M. Tone, H. Waldmann, L. Vaickus, and M. Rosenzweig. 2010. Enhancement of humoral and cellular immunity with an anti-glucocorticoid-induced tumour necrosis factor receptor monoclonal antibody. Immunology 130: 231-242.
14. Bulliard, Y., R. Jolicoeur, M. Windman, S. M. Rue, S. Ettenberg, D. A. Knee, N. S. Wilson, G. Dranoff, and J. L. Brogdon. 2013. Activating Fc g receptors contribute to the antitumor activities of immunoregulatory receptor-targeting antibodies. J. Exp. Med. 210: 1685-1693.
15. Nishioka, T., E. Nishida, R. Iida, A. Morita, and J. Shimizu. 2008. In vivo expansion of CD4+Foxp3+ regulatory T cells mediated by GITR molecules. Immunol. Lett. 121: 97-104.
16. Hu, P., R. S. Arias, R. E. Sadun, Y. C. Nien, N. Zhang, H. Sabzevari, M. E. Lutsiak, L. A. Khawli, and A. L. Epstein. 2008. Construction and preclinical characterization of Fc-mGITRL for the immunotherapy of cancer. Clin. Cancer Res. 14: 579-588.
17. Liao, G., S. Nayak, J. R. Regueiro, S. B. Berger, C. Detre, X. Romero, R. de Waal Malefyt, T. A. Chatila, R. W. Herzog, and C. Terhorst. 2010. GITR engagement preferentially enhances proliferation of functionally competent CD4 +CD25+FoxP3+ regulatory T cells. Int. Immunol. 22: 259-270.
18. Ronchetti, S., E. Ricci, M. G. Petrillo, L. Cari, G. Migliorati, G. Nocentini, and C. Riccardi. 2015. Glucocorticoid-induced tumour necrosis factor receptorrelated protein: a key marker of functional regulatory T cells. J. Immunol. Res. 2015: 171520.
19. Nocentini, G., S. Ronchetti, M. G. Petrillo, and C. Riccardi. 2012. Pharmacological modulation of GITRL/GITR system: therapeutic perspectives. Br. J. Pharmacol. 165: 2089-2099.
20. Cao, X., K. Leonard, L. I. Collins, S. F. Cai, J. C. Mayer, J. E. Payton, M. J. Walter, D. Piwnica-Worms, R. D. Schreiber, and T. J. Ley. 2009. Interleukin 12 stimulates IFN-gamma-mediated inhibition of tumor-induced regulatory T-cell proliferation and enhances tumor clearance. Cancer Res. 69: 8700-8709.
21. McHugh, R. S., M. J. Whitters, C. A. Piccirillo, D. A. Young, E. M. Shevach, M. Collins, and M. C. Byrne. 2002. CD4(+)CD25(+) immunoregulatory T cells: gene expression analysis reveals a functional role for the glucocorticoid-induced TNF receptor. Immunity 16: 311-323.
22. Ramirez-Montagut, T., A. Chow, D. Hirschhorn-Cymerman, T. H. A. A. Terwey, A. A. Kochman, S. Lu, R. C. Miles, S. Sakaguchi, A. N. Houghton, and M. R. van den Brink. 2006. Glucocorticoid-induced TNF receptor family related gene activation overcomes tolerance/ignorance to melanoma differentiation antigens and enhances antitumor immunity. J. Immunol. 176: 6434-6442.
23. Coe, D., S. Begom, C. Addey, M. White, J. Dyson, and J. G. Chai. 2010. Depletion of regulatory T cells by anti-GITR mAb as a novel mechanism for cancer immunotherapy. Cancer Immunol. Immunother. 59: 1367-1377.
24. Yu, P., Y. Lee, W. Liu, T. Krausz, A. Chong, H. Schreiber, and Y. X. Fu. 2005. Intratumor depletion of CD4+ cells unmasks tumor immunogenicity leading to the rejection of late-stage tumors. J. Exp. Med. 201: 779-791.
25. Choi, B. K., Y. H. Kim, W. J. Kang, S. K. Lee, K. H. Kim, S. M. Shin, W. M. Yokoyama, T. Y. Kim, and B. S. Kwon. 2007. Mechanisms involved in synergistic anticancer immunity of anti-4-1BB and anti-CD4 therapy. Cancer Res. 67: 8891-8899.
26. Croft, M. 2009. The role of TNF superfamily members in T-cell function and diseases. Nat. Rev. Immunol. 9: 271-285.
27. van Olffen, R. W., N. Koning, K. P. van Gisbergen, F. M. Wensveen, R. M. Hoek, L. Boon, J. Hamann, R. A. van Lier, and M. A. Nolte. 2009. GITR triggering induces expansion of both effector and regulatory CD4+ T cells in vivo. J. Immunol. 182: 7490-7500.
28. Carrier, Y., M. J. Whitters, J. S. Miyashiro, T. P. LaBranche, H. E. Ramon, S. E. Benoit, M. S. Ryan, S. P. Keegan, H. Guay, J. Douhan, et al. 2012. Enhanced GITR/GITRL interactions augment IL-27 expression and induce IL-10-producing Tr-1 like cells. Eur. J. Immunol. 42: 1393-1404.
29. Choi, B. K., J. S. Bae, E. M. Choi, W. J. Kang, S. Sakaguchi, D. S. Vinay, and B. S. Kwon. 2004. 4-1BB-dependent inhibition of immunosuppression by activated CD4+CD25+ T cells. J. Leukoc. Biol. 75: 785-791.
30. Stephens, L. A., D. Gray, and S. M. Anderton. 2005. CD4+CD25+ regulatory T cells limit the risk of autoimmune disease arising from T cell receptor crossreactivity. Proc. Natl. Acad. Sci. USA 102: 17418-17423.
31. Nakamura, K., A. Kitani, and W. Strober. 2001. Cell contact-dependent immunosuppression by CD4(+)CD25(+) regulatory T cells is mediated by cell surfacebound transforming growth factor beta. J. Exp. Med. 194: 629-644.
32. Thornton, A. M., and E. M. Shevach. 1998. CD4+CD25+ immunoregulatory T cells suppress polyclonal T cell activation in vitro by inhibiting interleukin 2 production. J. Exp. Med. 188: 287-296.
33. Onishi, Y., Z. Fehervari, T. Yamaguchi, and S. Sakaguchi. 2008. Foxp3+ natural regulatory T cells preferentially form aggregates on dendritic cells in vitro and actively inhibit their maturation. Proc. Natl. Acad. Sci. USA 105: 10113-10118.
34. Ronchetti, S., G. Nocentini, C. Riccardi, and P. P. Pandolfi. 2002. Role of GITR in activation response of T lymphocytes. Blood 100: 350-352.